In this latest Drug Pipeline Insights Report, Optum Rx highlights the four medications expected by the end of the second quarter of 2022. While these new drugs might be safer and more effective, they come at a cost.
The drugs in this report include treatments for:
A rare heart condition
Type 2 diabetes
A cardiovascular disease characterized by an abnormally thick heart muscle